149 related articles for article (PubMed ID: 34768211)
21. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
[TBL] [Abstract][Full Text] [Related]
22. Potential of lymph-node ratio as a prognostic factor for patients with oral squamous cell carcinoma.
Tomo S; Araújo WAF; de Castro TF; Neto SC; Collado FU; Biasoli ÉR; Bernabé DG; Miyahara GI
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e814-e821. PubMed ID: 35998818
[TBL] [Abstract][Full Text] [Related]
23. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
[TBL] [Abstract][Full Text] [Related]
24. Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma.
Dermody SM; McMichael BM; Bellile E; Marchiano EJ; Chinn SB
Oral Oncol; 2023 Nov; 146():106572. PubMed ID: 37742470
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma.
Struckmeier AK; Buchbender M; Lutz R; Agaimy A; Kesting M
Head Neck; 2024 May; 46(5):1083-1093. PubMed ID: 38501325
[TBL] [Abstract][Full Text] [Related]
27. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
[TBL] [Abstract][Full Text] [Related]
28. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
[TBL] [Abstract][Full Text] [Related]
29. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients?
Sayed SI; Sharma S; Rane P; Vaishampayan S; Talole S; Chaturvedi P; Chaukar D; Deshmukh A; Agarwal JP; D'cruz AK
J Surg Oncol; 2013 Sep; 108(4):256-63. PubMed ID: 23893514
[TBL] [Abstract][Full Text] [Related]
30. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy.
Liao CT; Hsueh C; Lee LY; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Tsao CK; Huang YC; Yen TC
Oral Oncol; 2012 Apr; 48(4):329-36. PubMed ID: 22104249
[TBL] [Abstract][Full Text] [Related]
31. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
32. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of metastatic nodal volume and lymph node ratio in patients with cervical lymph node metastases from an unknown primary tumor.
Park GC; Jung JH; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oncology; 2014; 86(3):170-6. PubMed ID: 24732431
[TBL] [Abstract][Full Text] [Related]
36. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancer.
Feng Z; Xu QS; Wang C; Li JZ; Mao MH; Li H; Qin LZ; Han Z
Sci Rep; 2017 Jul; 7(1):6708. PubMed ID: 28751709
[TBL] [Abstract][Full Text] [Related]
37. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
[TBL] [Abstract][Full Text] [Related]
38. Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
Arun I; Maity N; Hameed S; Jain PV; Manikantan K; Sharan R; Arun P
Head Neck; 2021 Feb; 43(2):520-533. PubMed ID: 33021340
[TBL] [Abstract][Full Text] [Related]
39. Utility of SUV
Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E
Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180
[TBL] [Abstract][Full Text] [Related]
40. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]